Science Explorer Interactive view Map
Topic · Cellular and Molecular Neuroscience

Nuclear Receptors and Signaling

Nuclear Receptors and Signaling is a research topic within Cellular and Molecular Neuroscience. Science Explorer counts 16k research works in it since 1951. 24.0% of them reached the world's top 10% most cited for their field and year.

This cluster of papers explores the Nurr1/CoREST pathway and its role in protecting dopaminergic neurons from inflammation-induced death, with implications for neurodegenerative diseases such as Parkinson's. The research covers topics such as mitochondrial targeting, nuclear receptors, transcriptional regulation, and apoptosis.

  • Nurr1
  • NR4A2
  • dopaminergic neurons
  • Parkinson's disease
  • inflammation
  • mitochondrial targeting
  • nuclear receptors
  • neurodegeneration
  • transcriptional regulation
  • apoptosis
Research works
16k
fractional, since 1951
In the world top 10%
3.9k
per year above
Top-10% rate
24.0%
share of its works in the world top 10%
Growth, 2013–17 → 2018–22
+10%
the tick is no change

Which countries lead Nuclear Receptors and Signaling research?

By volume, China and the United States publish the most (768 and 528 works in 2022–2025).

By volume, 2022–2025

  1. 1 China 768 works
  2. 2 United States 528 works
  3. 3 India 167 works
  4. 4 Germany 85 works
  5. 5 Japan 83 works
  6. 6 South Korea 79 works
  7. 7 United Kingdom 73 works
  8. 8 Italy 71 works
  9. 9 Canada 52 works
  10. 10 Spain 51 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

China: 39.2%United States: 27.0%India: 8.5%Germany: 4.4%6 others listed: 20.9%39%largest
China768 · 39.2%United States528 · 27.0%India167 · 8.5%Germany85 · 4.4%6 others listed408 · 20.9%

Shares of the rows listed above, not of the whole node.

Which institutions lead Nuclear Receptors and Signaling research?

By volume in 2022–2025, Central South University publishes the most Nuclear Receptors and Signaling research, followed by Chinese Academy of Medical Sciences & Peking Union Medical College and Sun Yat-sen University.

By volume, 2022–2025

  1. 1 Central South UniversityChina 12 works
  2. 2 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 11 works
  3. 3 Sun Yat-sen UniversityChina 10 works
  4. 4 Nanjing Medical UniversityChina 10 works
  5. 5 China Medical UniversityChina 9 works
  6. 6 Sichuan UniversityChina 9 works
  7. 7 Qingdao UniversityChina 8 works
  8. 8 Capital Medical UniversityChina 8 works
  9. 9 Yale UniversityUnited States 8 works
  10. 10 Harvard UniversityUnited States 8 works

Who are the leading researchers in Nuclear Receptors and Signaling?

The most-cited researchers publishing on Nuclear Receptors and Signaling include John Hardy and Eric Boerwinkle.

  1. 1 John Hardy United Kingdom 4k citations
  2. 2 Eric Boerwinkle United States 3.6k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

Where is Nuclear Receptors and Signaling research done?

The largest centres of Nuclear Receptors and Signaling research in 2022–2025 are Beijing (China), Shanghai (China), Guangzhou (China) and Nanjing (China).

Largest cities, 2022–2025

  1. 1 Beijing China 70 works
  2. 2 Shanghai China 55 works
  3. 3 Guangzhou China 51 works
  4. 4 Nanjing China 37 works
  5. 5 Seoul South Korea 35 works
  6. 6 Wuhan China 34 works
  7. 7 Changsha China 33 works
  8. 8 London United Kingdom 32 works
  9. 9 Hangzhou China 25 works
  10. 10 New York United States 25 works
See Nuclear Receptors and Signaling on the map

Where is the best place to study Nuclear Receptors and Signaling?

Among universities, judged by research, China Medical University, Qingdao University and Sun Yat-sen University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 26.175%fractional works in this node (log) →share in the world top 10% →China Medical University: 9, 32.7%Qingdao University: 8, 34.1%Sun Yat-sen University: 10, 31.3%Chinese Academy of Medical Sciences & Peking Union Medical College: 10, 26.3%Nanjing Medical University: 10, 18.4%Central South University: 12, 17.8%Sichuan University: 9, 25.4%Capital Medical University: 8, 23.4%Qingdao UniversityChina Medical Univer…Sun Yat-sen UniversityChinese Academy of M…
above the meannear itbelow it

One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.

#UniversityScoreTop 10%SpecialisationWorksGrowth
1 China Medical UniversityChina 65.432.7%11.9×9 -0.4%
2 Qingdao UniversityChina 60.634.1%6.0×8 +50.2%
3 Sun Yat-sen UniversityChina 54.031.3%2.5×10 +18.1%
4 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 44.226.3%4.5×10 -32.2%
5 Nanjing Medical UniversityChina 40.618.4%7.7×10 +28.8%
6 Central South UniversityChina 37.217.8%2.9×12 +8.4%
7 Sichuan UniversityChina 36.825.4%2.1×9 +54.5%
8 Capital Medical UniversityChina 27.823.4%5.8×8 -25.5%

Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.

Is Nuclear Receptors and Signaling research growing?

Output in 2018–2022 was 10% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Nuclear Receptors and Signaling.

19801990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.